Skip to content

Ehlers Danlos Syndrome Type 3 C0268337

Published: July 22, 2026Updated: August 20, 2026

A genetic disorder characterized by joint hypermobility and connective tissue laxity. It can affect multiple body systems and varies in severity. Management focuses on physical therapy, pain control, and preventing secondary issues.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest pain

Joint hypermobility

(musculoskeletal)

Joint pain or stiffness

(musculoskeletal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Skin hyperextensibility

(musculoskeletal)

Chronic joint pain

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Generalized Joint Hypermobility Physical Therapy

Physical therapy for hypermobile EDS focuses on core stabilization, postural training, and graded exercise to improve proprioception and muscle support around hypermobile joints. Programs are customized to prevent overuse injuries while building functional strength.

physical_therapy
3

Activity Modification and Pacing

Learning to pace activities and recognize pain signals helps prevent post-exertional malaise. Modifying movements that cause subluxations and incorporating rest breaks protects joints while maintaining function.

lifestyle

Additional treatment options

Pain Symptom Management

Comprehensive pain management may include topical treatments, oral analgesics, and muscle relaxants for associated myofascial pain. Medications are used as part of a broader multidisciplinary approach.

medication

Autonomic Dysfunction and GI Screening

Regular monitoring for orthostatic intolerance, gastrointestinal dysmotility, and mast cell activation common in hEDS. Screening allows for early intervention with appropriate specialists.

monitoring

Chronic Condition Psychological Therapy

Psychological support addresses the significant impact of chronic pain, fatigue, and functional limitations on quality of life. Therapy helps with acceptance, coping strategies, and managing the emotional burden of a lifelong condition.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Ehlers Danlos Syndrome Type 3 C0268337?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Malfait F, Francomano C, Byers P, et al. The 2017 International Consortium on the Ehlers-Danlos Syndromes. Am J Med Genet C Semin Med Genet. 2017;175(1):8-26.

guideline2017
2

Tinkle B, Castori M, Francomano C, et al. Hypermobile Ehlers-Danlos syndrome (hEDS): A review. Am J Med Genet A. 2017;173(9):2367-2378.

review2017
3

Hammon M, Krichbaum M, Stumpp CU, et al. Clinical and molecular characterization of hypermobile Ehlers-Danlos syndrome. Genes (Basel). 2021;12(7):1061.

other2021
4

Schubart JR, Bascom R, Graham R, et al. Pain and pain-related symptoms in hypermobile Ehlers-Danlos syndrome: A clinical trial. J Pain Res. 2020;13:2459-2469.

clinical_trial2020

Medication Comparisons

Compare medications used to treat Ehlers Danlos Syndrome Type 3 C0268337. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy